Analysts at StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Get Free Report) in a research ...
Wedbush upgraded shares of Bicara Therapeutics (NASDAQ:BCAX – Free Report) to a strong-buy rating in a research note released on Wednesday,Zacks.com reports. Other equities research analysts have also ...